Association of Monocyte Chemoattractant Protein-1 (MCP-1)-2518A>G Polymorphism with Susceptibility to Coronary Artery Disease: A Meta-Analysis

Annals of Human Genetics

Volumn 79, Issue 3, 2015, Pages 173-187

  Bai, Xiao Yan ^a   Li, Shujing ^a   Wang, Miao ^a   Qu, Xinjian ^a   Hu, Gaolei ^a   Xu, Zhaowei ^a   Chen, Min ^a   He, Guo Wei ^b   Wu, Huijian ^a  

^a DALIAN UNIVERSITY OF TECHNOLOGY   (China)

^b HANGZHOU NORMAL UNIVERSITY   (China)

Author keywords

Coronary artery disease; meta analysis; monocyte chemoattractant protein 1; polymorphism

Indexed keywords

MONOCYTE CHEMOTACTIC PROTEIN 1; CCL2 PROTEIN, HUMAN;

AFRICAN; ARTICLE; ASIAN; CAUCASIAN; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; CORONARY RISK; ETHNICITY; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENETIC MODEL; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; PREVALENCE; PRIORITY JOURNAL; SYSTEMATIC REVIEW; ALLELE; ASIAN CONTINENTAL ANCESTRY GROUP; BIOLOGICAL MODEL; GENETIC PREDISPOSITION; GENETICS; META ANALYSIS; RISK; RISK FACTOR;

ALLELES; ASIAN CONTINENTAL ANCESTRY GROUP; CHEMOKINE CCL2; CORONARY ARTERY DISEASE; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MODELS, GENETIC; ODDS RATIO; POLYMORPHISM, GENETIC; RISK FACTORS;

EID: 85027958663     PISSN: 00034800     EISSN: 14691809     Source Type: Journal    
DOI: 10.1111/ahg.12105     Document Type: Article

References (60)

1. Alioglu, E., Turk, U., Cam, S., Abbasaliyev, A., Tengiz, I., & Ercan, E. (2009) Polymorphisms of the methylenetetrahydrofolate reductase, vascular endothelial growth factor, endothelial nitric oxide synthase, monocyte chemoattractant protein-1 and apolipoprotein E genes are not associated with carotid intima-media thickness. Can J Cardiol 25, e1–5.
2. Bagos, P. G. (2008) A unification of multivariate methods for meta-analysis of genetic association studies. Stat Appl Genet Mol Biol 7, Article31. doi: 10.2202/1544-6115.1408.
3. Begg, C. B. & Mazumdar, M. (1994) Operating characteristics of a rank correlation test for publication bias. Biometrics 50, 1088–1101.
4. Benjamini, Y. & Hochberg, Y. (1995) Controlling the false discovery rate—A practical and powerful approach to multiple testing. J Roy Stat Soc B Met 57, 289–300.
5. Bielinski, S. J., Pankow, J. S., Miller, M. B., Hopkins, P. N., Eckfeldt, J. H., Hixson, J., Liu, Y., Register, T., Myers, R. H., & Arnett, D. K. (2007) Circulating MCP-1 levels shows linkage to chemokine receptor gene cluster on chromosome 3: The NHLBI family heart study follow-up examination. Genes Immun 8, 684–690.
6. Bjarnadottir, K., Eiriksdottir, G., Aspelund, T., & Gudnason, V. (2006) Examination of genetic effects of polymorphisms in the MCP-1 and CCR2 genes on MI in the Icelandic population. Atherosclerosis 188, 341–346.
7. Bowden, J., Tierney, J. F., Copas, A. J., & Burdett, S. (2011) Quantifying, displaying and accounting for heterogeneity in the meta-analysis of RCTs using standard and generalised Q statistics. BMC Med Res Methodol 11, 41. doi: 10.1186/1471-2288-11-41.
8. Bucova, M., Lietava, J., Mrazek, F., Petrkova, J., Bernadic, M., Buckingham, T., & Petrek, M. (2008) Association of chronic stable angina pectoris with MCP-1–2518 A/G single nucleotide polymorphism in the Slovak population. Clin Chim Acta 392, 71–72.
9. Bucova, M., Lietava, J., Mrazek, F., Petrkova, J., Penz, P., Bernadic, M., Buckingham, T. A., & Petrek, M. (2009a) The MCP-1 -2518 (A/G) single nucleotide polymorphism is associated with ischemic heart disease and myocardial infarction in men in the Slovak population. Bratisl Lek Listy 110, 385–389.
10. Bucova, M., Lietava, J., Penz, P., Mrazek, F., Petrkova, J., Bernadic, M., & Petrek, M. (2009b) Association of MCP-1 -2518 A/G single nucleotide polymorphism with the serum level of CRP in Slovak patients with ischemic heart disease, angina pectoris, and hypertension. Mediators Inflamm 2009, 390951. doi: 10.1155/2009/390951.
11. Cam, S. F., Sekuri, C., Sagcan, A., Ercan, E., Tengiz, I., Alioglu, E., & Berdeli, A. (2008) Effect of monocyte chemoattractant protein-1 (MCP-1) gene polymorphism in Turkish patients with premature coronary artery disease. Scand J Clin Lab Invest 68, 801–805.
12. Cermakova, Z., Petrkova, J., Arakelyan, A., Drabek, J., Mrazek, F., Lukl, J., & Petrek, M. (2005) The MCP-1 -2518 (A to G) single nucleotide polymorphism is not associated with myocardial infarction in the Czech population. Int J Immunogenet 32, 315–318.
13. Chen, D. Q., Zeng, Y., Zhou, J., Yang, L., Jiang, S., Huang, J. D., Lu, L., & Zheng, B. J. (2010) Association of candidate susceptible loci with chronic infection with hepatitis B virus in a Chinese population. J Med Virol 82, 371–378.
14. Christodoulidis, G., Vittorio, T. J., Fudim, M., Lerakis, S., & Kosmas, C. E. (2014) Inflammation in coronary artery disease. Cardiol Rev 22, 279–88. doi: 10.1097/CRD.0000000000000006.
15. Cushing, S. D., Berliner, J. A., Valente, A. J., Territo, M. C., Navab, M., Parhami, F., Gerrity, R., Schwartz, C. J., & Fogelman, A. M. (1990) Minimally modified low density lipoprotein induces monocyte chemotactic protein 1 in human endothelial cells and smooth muscle cells. Proc Natl Acad Sci U S A 87, 5134–5138.
16. Daissormont, I. T., Kraaijeveld, A. O., & Biessen, E. A. (2009) Chemokines as therapeutic targets for atherosclerotic plaque destabilization and rupture. Future Cardiol 5, 273–284.
17. Dawson, T. C., Kuziel, W. A., Osahar, T. A., & Maeda, N. (1999) Absence of CC chemokine receptor-2 reduces atherosclerosis in apolipoprotein E-deficient mice. Atherosclerosis 143, 205–211.
18. Deloukas, P., Kanoni, S., Willenborg, C., Farrall, M., Assimes, T. L., Thompson, J. R., Ingelsson, E., Saleheen, D., Erdmann, J., Goldstein, B. A., Stirrups, K., Konig, I. R., Cazier, J. B., Johansson, A., Hall, A. S., Lee, J. Y., Willer, C. J., Chambers, J. C., Esko, T., Folkersen, L., Goel, A., Grundberg, E., Havulinna, A. S., Ho, W. K., Hopewell, J. C., Eriksson, N., Kleber, M. E., Kristiansson, K., Lundmark, P., Lyytikainen, L. P., Rafelt, S., Shungin, D., Strawbridge, R. J., Thorleifsson, G., Tikkanen, E., Van Zuydam, N., Voight, B. F., Waite, L. L., Zhang, W., Ziegler, A., Absher, D., Altshuler, D., Balmforth, A. J., Barroso, I., Braund, P. S., Burgdorf, C., Claudi-Boehm, S., Cox, D., Dimitriou, M., Do, R., Doney, A. S., El Mokhtari, N., Eriksson, P., Fischer, K., Fontanillas, P., Franco-Cereceda, A., Gigante, B., Groop, L., Gustafsson, S., Hager, J., Hallmans, G., Han, B. G., Hunt, S. E., Kang, H. M., Illig, T., Kessler, T., Knowles, J. W., Kolovou, G., Kuusisto, J., Langenberg, C., Langford, C., Leander, K., Lokki, M. L., Lundmark, A., McCarthy, M. I., Meisinger, C., Melander, O., Mihailov, E., Maouche, S., Morris, A. D., Muller-Nurasyid, M., Nikus, K., Peden, J. F., Rayner, N. W., Rasheed, A., Rosinger, S., Rubin, D., Rumpf, M. P., Schafer, A., Sivananthan, M., Song, C., Stewart, A. F., Tan, S. T., Thorgeirsson, G., van der Schoot, C. E., Wagner, P. J., Wells, G. A., Wild, P. S., Yang, T. P., Amouyel, P., Arveiler, D., Basart, H., Boehnke, M., Boerwinkle, E., Brambilla, P., Cambien, F., Cupples, A. L., de Faire, U., Dehghan, A., Diemert, P., Epstein, S. E., Evans, A., Ferrario, M. M., Ferrieres, J., Gauguier, D., Go, A. S., Goodall, A. H., Gudnason, V., Hazen, S. L., Holm, H., Iribarren, C., Jang, Y., Kahonen, M., Kee, F., Kim, H. S., Klopp, N., Koenig, W., Kratzer, W., Kuulasmaa, K., Laakso, M., Laaksonen, R., Lind, L., Ouwehand, W. H., Parish, S., Park, J. E., Pedersen, N. L., Peters, A., Quertermous, T., Rader, D. J., Salomaa, V., Schadt, E., Shah, S. H., Sinisalo, J., Stark, K., Stefansson, K., Tregouet, D. A., Virtamo, J., Wallentin, L., Wareham, N., Zimmermann, M. E., Nieminen, M. S., Hengstenberg, C., Sandhu, M. S., Pastinen, T., Syvanen, A. C., Hovingh, G. K., Dedoussis, G., Franks, P. W., Lehtimaki, T., Metspalu, A., Zalloua, P. A., Siegbahn, A., Schreiber, S., Ripatti, S., Blankenberg, S. S., Perola, M., Clarke, R., Boehm, B. O., O'Donnell, C., Reilly, M. P., Marz, W., Collins, R., Kathiresan, S., Hamsten, A., Kooner, J. S., Thorsteinsdottir, U., Danesh, J., Palmer, C. N., Roberts, R., Watkins, H., Schunkert, H., & Samani, N. J. (2013) Large-scale association analysis identifies new risk loci for coronary artery disease. Nat Genet 45, 25–33.
19. Egger, M., Davey Smith, G., Schneider, M., & Minder, C. (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315, 629–634.
20. El Mahgoub, I. R., Afify, R. A., Aal, A. A., & Beda, D. G. (2011) Association between the monocyte chemoattractant protein-1 -2518G/A gene polymorphism and acute myocardial infarction patients among Egyptian population. Blood Coagul Fibrinolysis 22, 7–13.
21. Enjuanes, A., Benavente, Y., Hernandez-Rodriguez, J., Queralt, C., Yague, J., Jares, P., de Sanjose, S., Campo, E., & Cid, M. C. (2012) Association of NOS2 and potential effect of VEGF, IL6, CCL2 and IL1RN polymorphisms and haplotypes on susceptibility to GCA–a simultaneous study of 130 potentially functional SNPs in 14 candidate genes. Rheumatology (Oxford) 51, 841–851.
22. Gouvinhas, C., Severo, M., Azevedo, A., & Lunet, N. (2014) Worldwide patterns of ischemic heart disease mortality from 1980 to 2010. Int J Cardiol 170, 309–314.
23. Gu, L., Okada, Y., Clinton, S. K., Gerard, C., Sukhova, G. K., Libby, P., & Rollins, B. J. (1998) Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice. Mol Cell 2, 275–281.
24. Holm, S. (1979) A simple sequentially rejective multiple test procedure. Scand J Stat 6, 65–70.
25. Iwai, N., Kajimoto, K., Kokubo, Y., Okayama, A., Miyazaki, S., Nonogi, H., Goto, Y., & Tomoike, H. (2006) Assessment of genetic effects of polymorphisms in the MCP-1 gene on serum MCP-1 levels and myocardial infarction in Japanese. Circ J 70, 805–809.
26. Jemaa, R., Rojbani, H., Kallel, A., Ben Ali, S., Feki, M., Chabrak, S., Elasmi, M., Taieb, S. H., Sanhaji, H., Souheil, O., Mechmeche, R., & Kaabachi, N. (2008) Association between the -2518G/A polymorphism in the monocyte chemoattractant protein-1 (MCP-1) gene and myocardial infarction in Tunisian patients. Clin Chim Acta 390, 122–125.
27. Joven, J., Rull, A., Rodriguez-Gallego, E., Camps, J., Riera-Borrull, M., Hernandez-Aguilera, A., Martin-Paredero, V., Segura-Carretero, A., Micol, V., Alonso-Villaverde, C., & Menendez, J. A. (2013) Multifunctional targets of dietary polyphenols in disease: A case for the chemokine network and energy metabolism. Food Chem Toxicol 51, 267–279.
28. Kaur, R., Matharoo, K., Arora, P., & Bhanwer, A. J. (2013) Association of -2518A>G promoter polymorphism in the monocyte chemoattractant protein-1 (MCP-1) gene with type 2 diabetes and coronary artery disease. Genet Test Mol Biomarkers 17, 750–755.
29. Kim, M. P., Wahl, L. M., Yanek, L. R., Becker, D. M., & Becker, L. C. (2007) A monocyte chemoattractant protein-1 gene polymorphism is associated with occult ischemia in a high-risk asymptomatic population. Atherosclerosis 193, 366–372.
30. Lin, H. L., Ueng, K. C., Hsieh, Y. S., Chiang, W. L., Yang, S. F., & Chu, S. C. (2012) Impact of MCP-1 and CCR-2 gene polymorphisms on coronary artery disease susceptibility. Mol Biol Rep 39, 9023–9030.
31. McDermott, D. H., Yang, Q., Kathiresan, S., Cupples, L. A., Massaro, J. M., Keaney, J. F., Jr., Larson, M. G., Vasan, R. S., Hirschhorn, J. N., O'Donnell, C. J., Murphy, P. M., & Benjamin, E. J. (2005) CCL2 polymorphisms are associated with serum monocyte chemoattractant protein-1 levels and myocardial infarction in the Framingham Heart Study. Circulation 112, 1113–1120.
32. McGlinchey, P. G., Spence, M. S., Patterson, C. C., Allen, A. R., Murphy, G., Belton, C., & McKeown, P. P. (2004) Lack of association between the -2518G/A polymorphism of the MCP-1 gene and ischaemic heart disease: A family-based investigation. Tissue Antigens 64, 199–203.
33. Minelli, C., Thompson, J. R., Abrams, K. R., Thakkinstian, A., & Attia, J. (2005) The choice of a genetic model in the meta-analysis of molecular association studies. Int J Epidemiol 34, 1319–1328.
34. Mummidi, S., Bonello, G. B., & Ahuja, S. K. (2009) Confirmation of differential binding of Interferon Regulatory Factor-1 (IRF-1) to the functional and HIV disease-influencing -2578 A/G polymorphism in CCL2. Genes Immun 10, 197–198.
35. Nasibullin, T. R., Sadikova, R. I., Timasheva, Y. R., Tuktarova I. A, Erdman V. V., Khusainova L.N, Nikolaeva I. E., & E, M. O. (2014) Association between inflammatory gene polymorphisms and the risk of myocardial infarction. Russ J Genet 50, 211–217.
36. Page, S. H., Wright, E. K., Jr., Gama, L., & Clements, J. E. (2011) Regulation of CCL2 expression by an upstream TALE homeodomain protein-binding site that synergizes with the site created by the A-2578G SNP. PLoS One 6, e22052.
37. Pan, H., Niu, W., He, L., Wang, B., Cao, J., Zhao, F., Liu, Y., Li, S., & Wu, H. (2013) Contributory role of five common polymorphisms of RAGE and APE1 genes in lung cancer among Han Chinese. PLoS One 8, e69018.
38. Pham, M. H., Bonello, G. B., Castiblanco, J., Le, T., Sigala, J., He, W., & Mummidi, S. (2012) The rs1024611 regulatory region polymorphism is associated with CCL2 allelic expression imbalance. PLoS One 7, e49498.
39. Rollins, B. J., Morton, C. C., Ledbetter, D. H., Eddy, R. L., Jr., & Shows, T. B. (1991) Assignment of the human small inducible cytokine A2 gene, SCYA2 (encoding JE or MCP-1), to 17q11.2–12: Evolutionary relatedness of cytokines clustered at the same locus. Genomics 10, 489–492.
40. Ross, R. (1999) Atherosclerosis–an inflammatory disease. N Engl J Med 340, 115–126.
41. Rovin, B. H., Lu, L., & Saxena, R. (1999) A novel polymorphism in the MCP-1 gene regulatory region that influences MCP-1 expression. Biochem Biophys Res Commun 259, 344–348.
42. Sayols-Baixeras, S., Lluis-Ganella, C., Lucas, G., & Elosua, R. (2014) Pathogenesis of coronary artery disease: focus on genetic risk factors and identification of genetic variants. Appl Clin Genet 7, 15–32.
43. Simeoni, E., Winkelmann, B. R., Hoffmann, M. M., Fleury, S., Ruiz, J., Kappenberger, L., Marz, W., & Vassalli, G. (2004) Association of RANTES G-403A gene polymorphism with increased risk of coronary arteriosclerosis. Eur Heart J 25, 1438–1446.
44. Stang, A. (2010) Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol 25, 603–605.
45. Szalai, C., Duba, J., Prohaszka, Z., Kalina, A., Szabo, T., Nagy, B., Horvath, L., & Csaszar, A. (2001) Involvement of polymorphisms in the chemokine system in the susceptibility for coronary artery disease (CAD). Coincidence of elevated Lp(a) and MCP-1 -2518 G/G genotype in CAD patients. Atherosclerosis 158, 233–239.
46. Thakkinstian, A., McElduff, P., D'Este, C., Duffy, D., & Attia, J. (2005a) A method for meta-analysis of molecular association studies. Stat Med 24, 1291–1306.
47. Thakkinstian, A., McEvoy, M., Minelli, C., Gibson, P., Hancox, B., Duffy, D., Thompson, J., Hall, I., Kaufman, J., Leung, T. F., Helms, P. J., Hakonarson, H., Halpi, E., Navon, R., & Attia, J. (2005b) Systematic review and meta-analysis of the association between {beta}2-adrenoceptor polymorphisms and asthma: A HuGE review. Am J Epidemiol 162, 201–211.
48. Thakkinstian, A., Thompson, J. R., Minelli, C., & Attia, J. (2009) Choosing between per-genotype, per-allele, and trend approaches for initial detection of gene-disease association. J Appl Stat 36, 633–646.
49. van Wijk, D. F., van Leuven, S. I., Sandhu, M. S., Tanck, M. W., Hutten, B. A., Wareham, N. J., Kastelein, J. J., Stroes, E. S., Khaw, K. T., & Boekholdt, S. M. (2010) Chemokine ligand 2 genetic variants, serum monocyte chemoattractant protein-1 levels, and the risk of coronary artery disease. Arterioscler Thromb Vasc Biol 30, 1460–1466.
50. Wang, Q. B. & Zhang, Y. L. (2012) Correlation of MCP-1–2518 A/G gene polymorphism with acute myocardial infarction. Chinese Gen Pract 15, 1600–1602.
51. Wang, Y., Zhang, W., Li, S., Song, W., Chen, J., & Hui, R. (2011) Genetic variants of the monocyte chemoattractant protein-1 gene and its receptor CCR2 and risk of coronary artery disease: A meta-analysis. Atherosclerosis 219, 224–230.
52. Wei, J., Tang, Q., Liu, L., & Bin, J. (2013) Combination of peroxisome proliferator-activated receptor alpha/gamma agonists may benefit type 2 diabetes patients with coronary artery disease through inhibition of inflammatory cytokine secretion. Exp Ther Med 5, 783–788.
53. Xu, X., Wang, L. H., Liu, H. B., Xu, C. F., Zhang, P., Yong, F., & Shi, Y. P. (2013) [Association of chemokines and their receptors genes polymorphisms with risk of myocardial infarction]. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 30, 601–607.
54. Xuan, C., Bai, X. Y., Gao, G., Yang, Q., & He, G. W. (2011) Association between polymorphism of methylenetetrahydrofolate reductase (MTHFR) C677T and risk of myocardial infarction: A meta-analysis for 8,140 cases and 10,522 controls. Arch Med Res 42, 677–685.
55. Xuan, C., Lun, L. M., Zhao, J. X., Wang, H. W., Zhu, B. Z., Yu, S., Liu, Z., & He, G. W. (2013) PTPN22 gene polymorphism (C1858T) is associated with susceptibility to type 1 diabetes: A meta-analysis of 19,495 cases and 25,341 controls. Ann Hum Genet 77, 191–203.
56. Yang, L. X., Guo, R. W., Qi, F., Shi, Y. K., Wang, X. M., Ren, L., & Xu, A. F. (2012) Relationship between NFAT,MCP-1 with MCP-1–2518G/a gene polymorphism and coronary artery disease. Chinese Circ J 27, 278–281.
57. Zdravkovic, S., Wienke, A., Pedersen, N. L., & de Faire, U. (2007) Genetic influences on angina pectoris and its impact on coronary heart disease. Eur J Hum Genet 15, 872–877.
58. Zhang, X., Han, Y., Kang, J., & Yan, C. (2009) A monocyte chemoattractant protein-1 gene polymorphism is not associated with coronary artery disease in a Han Chinese population. Clin Chim Acta 403, 241–243.
59. Zhong, C., Luzhan, Z., Genshan, M., Jiahong, W., Xiaoli, Z., & Qi, Q. (2010) Monocyte chemoattractant protein-1–2518 G/A polymorphism, plasma levels, and premature stable coronary artery disease. Mol Biol Rep 37, 7–12.
60. Zintzaras, E. (2010) The generalized odds ratio as a measure of genetic risk effect in the analysis and meta-analysis of association studies. Stat Appl Genet Mol Biol 9, Article21. doi: 10.2202/1544-6115.1542.